Viewing StudyNCT00395629



Ignite Creation Date: 2024-05-05 @ 5:08 PM
Last Modification Date: 2024-10-26 @ 9:28 AM
Study NCT ID: NCT00395629
Status: COMPLETED
Last Update Posted: 2011-05-30
First Post: 2006-11-01

Brief Title: Safety and Efficacy of Deferasirox ICL670 in Patients With Iron Overload Resulting From Hereditary Hemochromatosis
Sponsor: Novartis Pharmaceuticals
Organization: Novartis

Conditions & Keywords Data

Conditions:
Name
Hereditary Hemochromatosis
Iron Overload
Keywords:
Name View
Transfusional Hemochromatosis View
Deferasirox View
ICL670A View
Iron chelators View
Deferiprone View